GTS Securities’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$214K Sell
1,013
-2,549
-72% -$549K 0.01% 1322
2025
Q4
$732K Buy
3,562
+2,058
+137% +$387K 0.03% 583
2025
Q3
$236K Buy
+1,504
New +$232K 0.01% 1188
2025
Q2
Sell
-11,555
Closed -$1.59M 1264
2025
Q1
$1.59M Buy
+11,555
New +$1.47M 0.07% 227
2024
Q4
Sell
-5,769
Closed -$638K 1676
2024
Q3
$638K Buy
5,769
+3,627
+169% +$379K ﹤0.01% 2592
2024
Q2
$211K Buy
+2,142
New +$218K ﹤0.01% 3409
2024
Q1
Sell
-6,807
Closed -$734K 3893
2023
Q4
$686K Sell
6,807
-21,611
-76% -$2.14M ﹤0.01% 2515
2023
Q3
$2.47M Buy
28,418
+18,306
+181% +$1.65M ﹤0.01% 1373
2023
Q2
$956K Buy
+10,112
New +$854K 0.03% 449

Other funds holding CAH

GTS Securities's CAH Position: Q1 2026 in Review

GTS Securities reduced its Cardinal Health (CAH) stake by 72% in Q1 2026, selling an estimated $549K and leaving 1,013 shares worth $214K. The position accounts for 0.01% of the portfolio, ranked #1322.

GTS Securities first reported a position in CAH in Q2 2023 and has held it in 9 quarters since. The position peaked at $2.47M in Q3 2023. 1,426 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • GTS Securities held 1,013 shares of Cardinal Health worth $214K as of Q1 2026.
  • GTS Securities sold 2,549 Cardinal Health shares in Q1 2026, an estimated $549K.
  • Cardinal Health made up 0.01% of GTS Securities's portfolio in Q1 2026, its #1322 holding.
  • GTS Securities first reported a position in Cardinal Health in Q2 2023 and has held it in 9 quarters since.
  • GTS Securities's Cardinal Health position peaked at $2.47M in Q3 2023.
  • 1,426 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.